Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03626753
Other study ID # CMNMonastir
Secondary ID
Status Completed
Phase Phase 2/Phase 3
First received
Last updated
Start date January 1, 2015
Est. completion date June 30, 2015

Study information

Verified date August 2018
Source Centre de Maternité de Monastir
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Many drugs with various mechanisms of action are used for postcaesarean pain relief. Although the response to pain relief is sometimes believed to be individual, it is very important to establish the most effective with the least adverse effects type of oral analgesia for women after caesarean section. Optimal pain control post-caesarean section will benefit not only the mother and her baby, but also a healthcare system. Optimal pain control may shorten the time spent in hospital after caesarean section and, therefore, reduce healthcare costs.


Description:

Pain after cesarean section (CS), usually described as strong, is an obstacle to good mother-child interaction and post-operative rehabilitation. Its management is important for a quick recovery and allow the mother to take care and link with her newborn. Currently, intrathecal opioids are the most commonly used technique and provide the foundation for post-cesarean analgesia. This technique combined with multimodal analgesia reduces the doses of morphine consumed, including these side effects. Spinal anesthesia is the standard anesthetic technique for caesarean section; it offers several advantages including the possibility of prescribing oral analgesics. An ideal analgesic protocol is one that is simple to implement, cost-effective, and has minimal impact on the work staff. It would have a good safety profile, a low incidence of side effects and complications, and respond to wide inter-patient variability. It relieves the mother of high quality pain while having minimal interference with her, newborn care and anesthesia while allowing safe breastfeeding.

The aim of this work is to compare the quality of an multimodal oral analgesia with intravenous analgesia and to demonstrate non-inferiority of the oral route pain relieve in postoperative caesarean section period. The secondary objectives was to evaluate the maternal tolerance of the drugs (piroxicam, nefopam, paracetamol) used postoperatively of a caesarean section.


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date June 30, 2015
Est. primary completion date June 30, 2015
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Pregnant in singleton pregnancy with gestational age > 34 weeks

- American society of anesthesiologists (ASA) physical status I-II.

Exclusion Criteria:

- history of gastrointestinal disorders predisposing to bleeding disorders such as ulcerative colitis,

- Crohn's disease,

- gastrointestinal cancers or diverticulitis,

- an active peptic ulcer,

- an inflammatory gastrointestinal disorder or a gastrointestinal haemorrhage,

- parturients who present preeclampsia,

- premature delivery (<32 weeks),

- constitutional or acquired coagulopathy,

- An antecedent of hemorrhage of the delivery,

- a hemorrhagic complication postoperatively,

- Anemia (hemoglobin less than 8g / 100ml),

- conversion of spinal anesthesia into general anesthesia,

- women with severe medical conditions: renal failure (preoperative creatinine clearance <30ml / min), heart or liver failure.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Nefopam 20 MG/ML
given by Oral route the dose of 20mg every 6 hours.
"Nefopam (Acupan)" 20 MG/ML Injectable Solution
given by intravenous route at the dose of 20mg every 6 hours.
"Acetaminophen, (paracetamol)" 500Mg Tab
2 tablets of "Acetaminophen (paracetamol)" 500Mg Tab administrated orally every 6 hours.
(Acetaminophen "paracetamol") IV Soln 10 MG/ML
Acetaminophen IV Soln 10 MG/ML, 1g paracetamol administrated intravenously every 6 hours.
(Piroxicam "piroxan") 20 MG Oral Tablet
2 tablets of "piroxicam (piroxan)" administrated orally once per 24 hours.
(Piroxicam "piroxan") 20Mg/1mL Injection
2 ampoules of (piroxicam "piroxan") administrated intravenously once per 24 hours.

Locations

Country Name City State
Tunisia Centre de Maternité de Monastir Monastir

Sponsors (1)

Lead Sponsor Collaborator
Centre de Maternité de Monastir

Country where clinical trial is conducted

Tunisia, 

References & Publications (2)

Mahajan L, Mittal V, Gupta R, Chhabra H, Vidhan J, Kaur A. Study to Compare the Effect of Oral, Rectal, and Intravenous Infusion of Paracetamol for Postoperative Analgesia in Women Undergoing Cesarean Section Under Spinal Anesthesia. Anesth Essays Res. 2017 Jul-Sep;11(3):594-598. doi: 10.4103/0259-1162.206872. — View Citation

Mkontwana N, Novikova N. Oral analgesia for relieving post-caesarean pain. Cochrane Database Syst Rev. 2015 Mar 29;(3):CD010450. doi: 10.1002/14651858.CD010450.pub2. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analogue Scale (VAS) pain from 0 - 10 (with 0 being no pain and 10 being the most severe pain imaginable) at rest and coughing or mobilization 24 hours postoperative
Secondary morphine consumption morphine consumption 24 hours postoperative
Secondary sides effects the occurrence of any undesirable effects related to the administration of any of the 3 drugs (nausea, vomiting, diarrhea, malaise, hypotension, sweating, convulsion, dryness of the mouth, tachycardia, palpitations, vertigo, allergic reactions) 24 hours postoperative
Secondary postoperative complications The occurrence of a postoperative complication (postpartum haemorrhage, blood transfusion, hysterectomy, etc). 24 hours post operative
See also
  Status Clinical Trial Phase
Completed NCT04633850 - Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
Recruiting NCT03181620 - Sedation Administration Timing: Intermittent Dosing Reduces Time to Extubation N/A
Completed NCT04579354 - Virtual Reality (VR) Tour to Reduce Preoperative Anxiety Before Anaesthesia N/A
Recruiting NCT06007378 - Optimizing Postoperative Pain Control After Laparoscopic Colorectal Surgery N/A
Recruiting NCT05943015 - Analgesic Efficacy of Quadratus Lumborum, Paravertebral Blocks N/A
Completed NCT04544228 - Ketamine or Neostigmine for Serratus Anterior Plane Block in Modified Radical Mastectomy N/A
Completed NCT03678168 - A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries N/A
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Completed NCT03663478 - Continuous TQL Block for Elective Cesarean Section Phase 4
Completed NCT04176822 - Designing Animated Movie for Preoperative Period N/A
Completed NCT05170477 - Influence of Apical Patency Concept Upon Postoperative Pain After Root Canal Treatment N/A
Not yet recruiting NCT04561856 - Fascia Iliaca Block Supplemented With Perineural Vs Intravenous Dexamethasone Phase 4
Completed NCT03612947 - TAP Block in Laparoscopic Cholecystectomy. Phase 2
Recruiting NCT05974501 - Pre vs Post Block in Total Knee Arthroplasty (TKA) Phase 4
Completed NCT05995912 - Efficacy and Safety of Etoricoxib-tramadol Tablet in Acute Postoperative Pain Phase 2
Completed NCT04571515 - Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain Phase 2
Active, not recruiting NCT04190355 - The Effect of Irrigant Types Used During Endodontic Treatment on Postoperative Pain N/A
Recruiting NCT05145153 - Incidence of Chronic Pain After Thoracic Surgery
Recruiting NCT03697278 - Monitoring Postoperative Patient-controlled Analgesia (PCA) N/A
Completed NCT03650998 - Transmuscular Quadratus Lumborum Block for Total Laparoscopic Hysterectomy. Phase 4